Drugs that contain Lubiprostone

1. List of Amitiza drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7064148 SUCAMPO PHARMA LLC Chloride channel opener
Aug, 2022

(9 months ago)

US8097653 SUCAMPO PHARMA LLC Dosage unit comprising a prostaglandin analog for treating constipation
Nov, 2022

(6 months ago)

US8389542 SUCAMPO PHARMA LLC Dosage unit comprising a prostaglandin analog for treating constipation
Nov, 2022

(6 months ago)

US6982283 SUCAMPO PHARMA LLC Method for treating drug-induced constipation
Dec, 2022

(6 months ago)

US7795312 SUCAMPO PHARMA LLC Method for treating abdominal discomfort
Sep, 2024

(1 year, 3 months from now)

US8748481 SUCAMPO PHARMA LLC Method for treating gastrointestinal disorder
Sep, 2025

(2 years from now)

US8779187 SUCAMPO PHARMA LLC Soft-gelatin capsule formulation
Jan, 2027

(3 years from now)

US8338639 SUCAMPO PHARMA LLC Soft-gelatin capsule formulation
Jan, 2027

(3 years from now)

US8026393 SUCAMPO PHARMA LLC Soft-gelatin capsule formulation
Oct, 2027

(4 years from now)

Do you want to check out AMITIZA patents from before 2022?

Market Authorisation Date: 31 January, 2006

Treatment: Method for treating constipation in a patient with opioid-induced constipation by opening cic channels; Method of treating constipation in a patient with irritable bowel syndrome by opening chloride c...

Dosage: CAPSULE;ORAL

How can I launch a generic of AMITIZA before it's patent expiration?
More Information on Dosage

AMITIZA family patents

25

United States

18

Japan

11

Argentina

8

Korea, Republic of

8

European Union

7

China

6

Canada

6

Spain

6

Brazil

5

Australia

5

New Zealand

5

Mexico

5

Taiwan

4

Denmark

4

Portugal

3

Norway

2

Israel

2

Austria

2

Russia

1

Luxembourg

1

Cyprus

1

Hong Kong

1

Germany

1

South Africa

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic